Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 762506, 8 pages
http://dx.doi.org/10.1155/2015/762506
Research Article

Statins Increase the Frequency of Circulating CD4+FOXP3+ Regulatory T Cells in Healthy Individuals

1Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Calle 70 No. 52-21, Medellín, Colombia
2Epiontis GmbH, 12489 Berlin, Germany
3Division of Immunobiology, Department of Pediatrics, Cincinnati Children’s Hospital Research Foundation, Cincinnati, OH 45229, USA

Received 3 December 2014; Accepted 8 February 2015

Academic Editor: Hiroshi Nakajima

Copyright © 2015 Ana Lucía Rodríguez-Perea et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Dhamne, Y. Chung, A. M. Alousi, L. J. N. Cooper, and D. Q. Tran, “Peripheral and thymic Foxp3+ regulatory T cells in search of origin, distinction, and function,” Frontiers in Immunology, vol. 4, article 253, Article ID Article 253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. K. Abbas, C. Benoist, J. A. Bluestone et al., “Regulatory T cells: recommendations to simplify the nomenclature,” Nature Immunology, vol. 14, no. 4, pp. 307–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Baron, S. Floess, G. Wieczorek et al., “DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells,” European Journal of Immunology, vol. 37, no. 9, pp. 2378–2389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Wang, A. Ioan-Facsinay, E. I. H. van der Voort, T. W. J. Huizinga, and R. E. M. Toes, “Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells,” European Journal of Immunology, vol. 37, no. 1, pp. 129–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kmieciak, M. Gowda, L. Graham et al., “Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function,” Journal of Translational Medicine, vol. 7, article 89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. A. M. Povoleri, C. Scottá, E. A. Nova-Lamperti, S. John, G. Lombardi, and B. Afzali, “Thymic versus induced regulatory T cells-who regulates the regulators?” Frontiers in Immunology, vol. 4, article 169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Liesz, E. Suri-Payer, C. Veltkamp et al., “Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke,” Nature Medicine, vol. 15, no. 2, pp. 192–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Greenwood, L. Steinman, and S. S. Zamvil, “Statin therapy and autoimmune disease: from protein prenylation to immunomodulation,” Nature Reviews Immunology, vol. 6, no. 5, pp. 358–370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Mausner-Fainberg, G. Luboshits, A. Mor et al., “The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells,” Atherosclerosis, vol. 197, no. 2, pp. 829–839, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T.-T. Tang, Y. Song, Y.-J. Ding et al., “Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis,” Journal of Lipid Research, vol. 52, no. 5, pp. 1023–1032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Arruvito, M. Sanz, A. H. Banham, and L. Fainboim, “Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction,” Journal of Immunology, vol. 178, no. 4, pp. 2572–2578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Presicce, M. E. Moreno-Fernandez, C. S. Lages, K. I. Orsborn, and C. A. Chougnet, “Association of two clones allows for optimal detection of human FOXP3,” Cytometry Part A, vol. 77, no. 6, pp. 571–579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Sehouli, C. Loddenkemper, T. Cornu et al., “Epigenetic quantification of tumor-infiltrating T-lymphocytes,” Epigenetics, vol. 6, no. 2, pp. 236–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Wu, M. Borde, V. Heissmeyer et al., “FOXP3 controls regulatory T cell function through cooperation with NFAT,” Cell, vol. 126, no. 2, pp. 375–387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Yilmaz, C. Reiss, A. Weng et al., “Differential effects of statins on relevant functions of human monocyte-derived dendritic cells,” Journal of Leukocyte Biology, vol. 79, no. 3, pp. 529–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Peng, J. Jin, S. Giri et al., “Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis,” Journal of Neuroimmunology, vol. 178, no. 1-2, pp. 130–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Koopman, D. Mortier, S. Hofman et al., “Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques,” Journal of General Virology, vol. 90, no. 4, pp. 915–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. E. Sousa, J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. M. Victorino, “CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load,” Journal of Immunology, vol. 169, no. 6, pp. 3400–3406, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Ghittoni, L. Patrussi, K. Pirozzi et al., “Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases,” The FASEB Journal, vol. 19, no. 6, pp. 605–607, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. P. Hickman, J. Yang, R. M. Thomas, A. D. Wells, and L. A. Turka, “Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells,” Journal of Immunology, vol. 177, no. 4, pp. 2186–2194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Mira, B. León, D. F. Barber et al., “Statins induce regulatory T cell recruitment via a CCL1 dependent pathway,” The Journal of Immunology, vol. 181, no. 5, pp. 3524–3534, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. E. Feig, Y. Shang, N. Rotllan et al., “Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages,” PLoS ONE, vol. 6, no. 12, Article ID e28534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. C. Kim, K. K. Kim, and E. M. Shevach, “Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-β signal transduction,” Immunology, vol. 130, no. 4, pp. 484–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. L. Kodach, R. J. Jacobs, P. W. Voorneveld et al., “Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway,” Gut, vol. 60, no. 11, pp. 1544–1553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Ohkura, M. Hamaguchi, H. Morikawa et al., “T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development,” Immunity, vol. 37, no. 5, pp. 785–799, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Rodríguez-Vita, E. Sínchez-Galín, B. Santamaría et al., “Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation,” PLoS ONE, vol. 3, no. 12, Article ID e3959, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Porreca, C. Di Febbo, G. Baccante, M. Di Nisio, and F. Cuccurullo, “Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin,” Journal of the American College of Cardiology, vol. 39, no. 11, pp. 1752–1757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Mao, W. Xiao, H. Liu et al., “Systematic evaluation of 640 FDA drugs for their effect on CD4+Foxp3+ regulatory T cells using a novel cell-based high throughput screening assay,” Biochemical Pharmacology, vol. 85, no. 10, pp. 1513–1524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Chen, W. Jin, N. Hardegen et al., “Conversion of peripheral CD4+CD25 Naive T Cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3,” The Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875–1886, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. M.-F. Zhao, X.-J. Qu, J.-L. Qu et al., “The role of E3 ubiquitin ligase Cbl proteins in interleukin-2-induced Jurkat T-cell activation,” BioMed Research International, vol. 2013, Article ID 430861, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Yamashita, K. Tsubakio-Yamamoto, T. Ohama, Y. Nakagawa-Toyama, and M. Nishida, “Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions,” Journal of Atherosclerosis and Thrombosis, vol. 17, no. 5, pp. 436–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. A. J. Wilhelm, M. Zabalawi, J. S. Owen et al., “Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr -/-, ApoA-I-/- mice,” The Journal of Biological Chemistry, vol. 285, no. 46, pp. 36158–36169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Mahmoud and E. Al-Ozairi, “Inflammatory cytokines and the risk of cardiovascular complications in type 2 diabetes,” Disease Markers, vol. 35, no. 4, pp. 235–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Kaji, “High-density lipoproteins and the immune system,” Journal of Lipids, vol. 2013, Article ID 684903, 8 pages, 2013. View at Publisher · View at Google Scholar
  35. R. Klingenberg, N. Gerdes, R. M. Badeau et al., “Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis,” Journal of Clinical Investigation, vol. 123, no. 3, pp. 1323–1334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. D. A. Forero-Peña and F. R. S. Gutierrez, “Statins as modulators of regulatory T-cell biology,” Mediators of Inflammation, vol. 2013, Article ID 167086, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Pencina, A. M. Navar-Boggan, R. B. D'Agostino Sr. et al., “Application of new cholesterol guidelines to a population-based sample,” The New England Journal of Medicine, vol. 370, no. 15, pp. 1422–1431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. I. K. Gratz and D. J. Campbell, “Organ-specific and memory treg cells: specificity, development, function, and maintenance,” Frontiers in Immunology, vol. 5, article 333, 2014. View at Publisher · View at Google Scholar